Generic Products

Why Generics?

At Mylan, we have one global quality standard in everything we do.

Because there is nothing generic about our standards. Our internal teams conduct reviews of all products, start to finish. No matter where in the world they are made.

Why such high standards? Because we truly care about the people who will be helped by the medicines we make. And we believe in earning that trust, from physicians, pharmacists, other healthcare professionals and patients, every day. It’s why we say, “Our Mylan Is Your Mylan.”

Want to know more about generic medicines? See the facts, figures and bioequivalence requirements below.

  • Percentage of U.S. prescriptions filled with a generic medicine

  • Mylan Market Share

    Number of U.S. prescriptions, brand-name or generic, filled with a Mylan product

  • FDA Logo

    Food and Drug Administration: This agency must approve every generic medicine before it can be sold in the U.S.

  • Bioequivalence

    To gain FDA approval, generic medicines must be proven to be “bioequivalent” to their brand name counterparts. That means generic and brand name medicines are the same in the following ways:

    • Active ingredient
    • Maximum amount of medicine in the blood at any given time
    • Total amount of medicine in the blood from the time it’s taken until the body eliminates it
    • Strength and dosage
    • Route of administration—tablet, injection, etc.
    • Expected safety and efficacy
    • FDA evaluation of manufacturing facilities

    Just because products have the same active ingredient does not mean they are bioequivalent. Once generic bioequivalence is proven, the FDA considers a generic medicine interchangeable with the brand name medicine.

  • Generic Drug Savings

    Average amount consumers can save by filling a prescription with a generic rather than a brand name medicine. The price of generic medicines is usually lower, when compared to brand name medicines, since they are not invented from scratch, generally subject to clinical trials or supported by advertising campaigns

  • Health Care Savings
    $1.46 Trillion! According to IMS Health, generic medications saved the U.S. healthcare system an estimated $1.46 trillion from 2006 to 2015, and $227 billion in 2015 alone. 
  • Pharma Industry Trends

    Main factors behind the growth of the generics industry

    • Aging population
    • Desire to reduce healthcare spending
  • Mylan Innovation

    The key to Mylan’s ability to bring new generics to market, especially medicines that are difficult-to-manufacture and difficult-to-formulate. Find out about our therapeutic innovation.

Generics Information Center


Discover why it’s so important to everyone at Mylan.

Learn more

Choosing Generics With Confidence

Find out more about the safety and bioequivalency of generic medicines.

Learn. Choose. Act.

Therapeutic Innovation

Our worldwide research and development group includes approximately 3,000 scientists and regulatory experts who innovate every day.

Key categories